Ken Ren
CASI pharmaceuticals, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ken Ren as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:36 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02234986 · A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar CarcinomaCASI pharmaceuticals, Inc. · completed · Advanced Adult Hepatocellular Carcinoma, Advanced Fibrolamellar Carcinoma · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 13 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:36 UTC. The ranking covers the 200 most relevant of 32 PubMed records, and a shared surname and initials can bring in a namesake. All 32 on PubMed
- Wearable sensor-based gait analysis to discriminate early Parkinson's disease from essential tremor.J Neurol · 202350 citationsRCR 9.3
- Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma.Oncologist · 202044 citationsRCR 1.9
- Potassium supplementation inhibits IL-17A production induced by salt loading in human T lymphocytes via p38/MAPK-SGK1 pathway.Exp Mol Pathol · 201630 citationsRCR 1.2
- Elevation of Fasting Ghrelin in Healthy Human Subjects Consuming a High-Salt Diet: A Novel Mechanism of Obesity?Nutrients · 201630 citationsRCR 1.3
- Effects of Post-Surgical Parenteral Nutrition on Patients with Gastric Cancer.Cell Physiol Biochem · 201827 citationsRCR 1.5
- Genetic variants in adiponectin and blood pressure responses to dietary sodium or potassium interventions: a family-based association study.J Hum Hypertens · 201625 citationsRCR 1.0
- Effect of salt intake and potassium supplementation on serum renalase levels in Chinese adults: a randomized trial.Medicine (Baltimore) · 201424 citationsRCR 1.0
- Insulin increases leptin mRNA expression in abdominal subcutaneous adipose tissue in humans.Mol Genet Metab · 200022 citationsRCR 0.6
- 22 citationsRCR 2.2
- [Effects of virtual reality training on limb movement in children with spastic diplegia cerebral palsy].Zhongguo Dang Dai Er Ke Za Zhi · 201619 citationsRCR 1.3